Crop Life Science
- Market cap
- ₹ 128 Cr.
- P/E
- 21.4x
- P/B
- 1.51x
- 52-week range
- 39.05 – 92.25
- ROE
- 8%
- ROCE
- 12%
- Dividend yield
- 0%
- Debt / equity
- 0.67
- Sector
- Fertilizers & Agrochemicals
- Industry
- Pesticides & Agrochemicals
- Listed on
- NSE SME
About
Crop Life Science Limited is an India-based company, which manufactures crop protection chemicals. The Company is engaged in the business of manufacturing and dealing in pesticides, insecticides, herbicide, fertilizers, and allied products related to research and technical formulations. It manufactures a diverse range of goods including Insecticides, Fungicides, Herbicides, Micro fertilizers, Bio-Pesticides, BioFertilizers, plant growth regulators, and soil plant health solutions. Its insecticides products include Ladayak, Leothrin, Interex, Imigrow, Rabid, Profkel Super, Larbotin, Tanja-50, ADO 70, Sazedar, Shamsher, Cropdon, Bakhtar, Athoxam, QVIDIC, Hexakill, Armeezin, Astu, Libra, Chhalang, Fencro, Toras, and Mufasa. Its fungicides products include Trovizol, Life Care, Ambucrop, Ibex, Mancostar M-45, Protozone, Thiocrop, Eelaj, Rustblast, Dadubar, and Cyclonex. The Company’s manufacturing plant is located at Ankleshwar, Gujrat.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Pesticides & Agrochemicals: 33 companies →Crop Life Science against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)21.4 against a typical 23.3: cheaper than most peers (1st = cheapest).14th of 33
- Sales growth−13.9% against a typical −4.5% from a year earlier.26th of 31
- Profit growth+33.3% against a typical +15.2% from a year earlier.10th of 25
- Share price, 3 months+32.3% against a typical −15.5%.1st of 32
- Size₹ 127.6 Cr. market value against a typical ₹ 883.3 Cr. (1st = largest).24th of 31
Latest announcements
Exchange filings and their impact on the company.
- Two independent directors resigned and UAE subsidiary plan deferred; committees reconstituted with no immediate financial impact.
Crop Life Science said its board on October 10, 2026 deferred the plan to set up a wholly owned subsidiary in Sharjah, UAE, to a later date. It also noted the resignation of two independent directors, Harendra Sevak and Devang Parekh, and reconstituted its audit, stakeholder, nomination and CSR committees. There is no immediate financial impact, with overseas expansion on hold and normal business continuing.
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 10 Oct 2026 | Other business matters | To consider other business matters |
| 24 Aug 2026 | Other business matters | To consider other business matters |
| 30 Jul 2026 | Other business matters | To consider other business matters |
| 26 May 2026 | Financial Results | To consider and approve the financial results for the period ended March 31, 2026 |
| 20 May 2026 | Other business matters | To consider other business matters |
| 10 Apr 2026 | Other business matters | To consider other business matters as mentioned. |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 79 | 52 | 97 | 101 | 106 | 94 | 120 | 87 |
| Expenses | 75 | 45 | 91 | 95 | 98 | 87 | 112 | 78 |
| Operating Profit | 5 | 7 | 6 | 6 | 8 | 8 | 8 | 9 |
| OPM % | 6% | 13% | 7% | 6% | 8% | 8% | 7% | 10% |
| Other Income | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
| Interest | 1 | 2 | 1 | 2 | 2 | 2 | 3 | 3 |
| Depreciation | 1 | 3 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | 2 | 3 | 4 | 4 | 4 | 5 | 4 | 6 |
| Tax % | 62% | −1% | 20% | 32% | 23% | 30% | 26% | 32% |
| Net Profit | 1 | 3 | 3 | 3 | 3 | 3 | 3 | 4 |
| EPS in Rs | 0.78 | 2.61 | 1.96 | 1.56 | 2.01 | 1.86 | 1.88 | 2.19 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- 14%
- 3 Years
- 16%
- TTM
- 3%
- 10 Years
- —
- 5 Years
- 14%
- 3 Years
- 19%
- TTM
- 4%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 15%
- TTM
- —
- 10 Years
- —
- 5 Years
- 9%
- 3 Years
- 9%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Crop Life Science | ₹ 82.00 | ₹ 128 Cr. | 21.4x | 1.5x | 8% | — |
| Asian Paints | ₹ 2,305.00 | ₹ 2,21,095 Cr. | 58.1x | 12.1x | 21.2% | 12.4% |
| Solar Industries India | ₹ 18,320.00 | ₹ 1,65,778 Cr. | 99.6x | 26.6x | 31.4% | 17.7% |
| Pidilite Industries | ₹ 1,514.00 | ₹ 1,54,107 Cr. | 64.8x | 14.7x | 23.8% | 16.9% |
| SRF | ₹ 2,309.00 | ₹ 68,444 Cr. | 44.6x | 6.1x | 13.8% | 11.6% |
| Linde India | ₹ 5,697.00 | ₹ 48,586 Cr. | 110.5x | 14.2x | 13.6% | 21.7% |
Management
- Rajvi Nikunj Shah
- Chief Financial Officer
- Sherry Kallil Sunny
- Compliance Officer, Company Secretary
- Rajesh Vrajlal Lunagariya
- Managing Director
- Ashvinkumar Ravjibhai Lunagaria
- Whole Time Director
- Chunilal Samajubhai Virolia
- Whole Time Director
Prices are delayed and for information only. Nothing on this page is investment advice.